Dashboard
Analysis
Charting
Screener
Resources
Settings
NYSE-XOM
Mar '15
Dec '16
Sep '18
Jun '20
Mar '22
Dec '23
Sep '25
Trailing Valuation
Stock Price
112.8
107.8
118.9
107.6
117.2
115.1
Total Shares Outstanding
4,217.2
4,263.2
4,309.8
4,353
4,395.5
4,442.8
Market Cap
475,485.4
459,578
512,569.1
468,252.2
515,239.8
511,458.2
Total Enterprise Value (TEV)
511,314.4
490,225
538,694.1
493,676.2
538,625.8
536,017.2
Dividend Yield
3.5%
3.6%
3.3%
Buyback Yield
4.3%
4.6%
4.2%
3.4%
Debt Paydown Yield
0.9%
1.1%
1.6%
1%
0.7%
Shareholder Yield
5.2%
5.7%
5.8%
5.3%
4.1%
P/S
1.5
1.4
P/Gross Profit
4.9
4.7
5.1
5
P/E
16.4
15.3
15.8
13.7
14.6
13.8
Earnings Yield
6.1%
6.5%
6.3%
7.3%
6.9%
P/OCF
9.2
8.5
9.6
9.1
9.3
P/FCF
20
18.2
15.2
15.7
FCF Yield
5%
5.5%
6.6%
6.4%
P/B
1.8
2
1.9
EV/Sales
1.6
EV/Gross Profit
5.3
5.4
EV/EBITDA
7.9
7.8
8.3
8.4
EV/EBIT
14.5
13.1
12.5
13.5
13.2
EV/OCF
9.9
9
10.1
9.5
9.8
EV/FCF
21.5
16.8
19.1
16.1
16.5
Dividends
DPS
4
3.9
3.8
Payout Ratio
57.5%
55.6%
51.9%
49.6%
48%
45.7%
Margins
Gross Profit Margin
30%
29.6%
29.5%
29.9%
Operating Margin
10.9%
11.3%
11.6%
11.7%
11.8%
11.9%
EBITDA Margin
18.5%
18.8%
18.7%
18.6%
19%
Net Profit Margin
9.6%
9.8%
10.2%
10.3%
10.4%
Effective Tax Rate
27.7%
28.4%
28.2%
28.3%
29.3%
Pre-Tax Profit Margin
13.2%
13.7%
14.2%
14.4%
14.6%
14.8%
Free Cash Flow Margin
8.8%
8.3%
9.1%
9.5%
OCF / Sales
15.9%
16.5%
15.7%
16.2%
16.6%
16.1%
OCF / Net Income
165.6%
168%
154.4%
156.9%
160.8%
154.6%
FCF / OCF
46.1%
53.6%
52.9%
55.8%
58%
59.1%
FCF / Net Income
76.4%
90.1%
81.6%
87.6%
93.3%
91.3%
FCF / EBITDA
39.5%
47%
44.3%
48.8%
50.7%
51.1%
Capital Efficiency
Return on Invested Capital
6.8%
7.2%
7.6%
8.6%
8.5%
8.7%
Return on Assets
5.6%
5.9%
6.2%
Return on Equity
11.5%
12%
12.8%
14.5%
Return on Total Capital
26.7%
30.4%
35%
34.4%
34.8%
Return on Capital Employed
9.3%
11.4%
Return on Tangible Assets
8.4%
Receivables Turnover
7.3
7.7
7.6
Days Sales Outstanding
50
47.4
48.3
43.9
42.7
43.4
Payables Turnover
3.6
Days Payables Outstanding
101.6
95.8
95.6
91.1
90.9
90.3
Inventory Turnover
9.4
10
9.7
Days Inventory Outstanding
40.7
38.7
36.6
37.1
37.6
37.9
Cash Conversion Cycle
-10.9
-9.7
-10.6
-10
-8.9
Asset Turnover
0.7
0.8
Fixed Asset Turnover
1.1
1.2
1.3
Operating Cycle
90.7
86
84.9
81.1
80.3
81.4
CapEx to OCF
0.5
0.4
CapEx to Revenue
0.1
CapEx to Depreciation
1
Financial Health
Total Debt
42,036
38,989
37,551
41,710
42,550
43,186
Net Debt
28,167
23,278
19,039
18,523
15,578
16,698
Current Ratio
Quick Ratio
0.9
Cash Ratio
0.2
0.3
Debt Ratio
Assets to Equity
1.7
Cash Flow to Debt Ratio
Long-term Debt to Assets
Net Current Asset Value
-105,274
-99,896
-97,955
-97,780
-98,975
-96,064
Debt / Equity
Total Debt / Capitalization
Long Term Debt / Capitalization
Long-Term Debt / Equity
Net Debt / EBITDA
EBIT / Interest Expense
48
43.7
40.1
39.7
41.2
43.6
EBITDA / Interest Expense
81.7
72.5
65
63.2
66.6
68
(EBITDA - Capex) / Interest Expense
44.1
43.1
39.3
38.8
42.2
Per Share
Revenue per Share
74.7
75
77.4
78.9
81
83.3
Basic EPS
6.9
7
7.5
8
Diluted EPS
Book Value per Share
59.9
59.8
61.4
64
65.7
Tangible Book Value per Share
Cash per Share
3.2
4.2
6.4
6.5
Operating Cash Flow per Share
11.8
12.4
12.1
12.8
13.4
Free Cash Flow per Share
5.5
6.6
7.1
CapEx per Share
5.7
5.6
Weighted Avg. Shares Outstanding
4,350.3
4,394.5
4,391
4,298
4,196.8
4,087.5
Weighted Avg. Shares Outstanding Diluted
Common Size
SG&A to Revenue
3%
2.9%
